Health Canada Considers Approving Trikafta for Ages 6–11

Health Canada Considers Approving Trikafta for Ages 6–11

310589

Health Canada Considers Approving Trikafta for Ages 6–11

Health Canada has granted priority review to an application that seeks to expand the approval of Trikafta to cover children with cystic fibrosis (CF) as young as 6 years. “We are pleased that [the application] has been accepted for Priority Review by Health Canada and we look forward to bringing this product to patients as soon as possible,” Duncan McKechnie said in a press release. McKechnie is senior vice president of North America commercial operations at…

You must be logged in to read/download the full post.